TIWN
Washington, March 23 (TIWN) The US Food and Drug Administration (FDA) has authorised the first-ever rapid test that can diagnose COVID-19 disease in 45 minutes.
The authorization was made Friday and tests will begin shipping next week, according to a statement from California-based Cepheid, the company manufacturing the tests.
"During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities," said Dr. David Persing, MD, Ph.D., chief medical and technology officer at Cepheid.
"An accurate test delivered close to the patient can be transformative -- and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources," Persing added.
- 71 killed, 67 injured in rain-related accidents in Pakistan
- NASA head Nelson says China hiding military presence in space
- Israel vows 'appropriate response' if Iran attacks its territory
- Musk confirms India visit, to meet PM Modi
- Multinationals view India as alternative manufacturing base; investments 'strong': UN